MINKOW EMILY (Chief Business Officer) reported 1 transaction at PREVAIL THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/26/2021ACC: 0001209191-21-005432
Officer· Chief Business Officer
Since Jun 2019
-429.75K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
429.75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13K
Price / share
—
Trade value
—
% of position
New position
1/22/2021
13K→0.00
Total
Net shares
−13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2021 | U · U | −13K | — | — | New position | 13K | 0.00 |
| Total | −13K | $0.00 | ||||||
Derivative Transactions4
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
149K shares
Shares
−149K
Strike price
0.18
Held after
0.00
Exercisable
—
1/22/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
104.89K shares
Shares
−104.89K
Strike price
0.18
Held after
0.00
Exercisable
—
1/22/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
108.85K shares
Shares
−108.85K
Strike price
10.26
Held after
0.00
Exercisable
—
1/22/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
54K shares
Shares
−54K
Strike price
16.91
Held after
0.00
Exercisable
—
1/22/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock149K shares | 1/22/2021 | D · Disposition | −149K | 0.18 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock104.89K shares | 1/22/2021 | D · Disposition | −104.89K | 0.18 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock108.85K shares | 1/22/2021 | D · Disposition | −108.85K | 10.26 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock54K shares | 1/22/2021 | D · Disposition | −54K | 16.91 | — | 0.00 |